Soluble CD59 as a Complement Inhibitor in Liver Endothelium
Author Information
Author(s): Jarel Gandhi, Siobhan M. Cashman, Rajendra Kumar-Singh
Primary Institution: Tufts University School of Medicine
Hypothesis
Can soluble CD59 expressed from an adenovirus inhibit complement deposition on murine liver vascular endothelium?
Conclusion
The study demonstrates that non membrane-targeted soluble CD59 can significantly inhibit complement deposition on murine liver vasculature when expressed in vivo from an adenovirus.
Supporting Evidence
- Soluble CD59 significantly reduced MAC deposition in liver endothelial cells.
- Intraperitoneal injection of adenovirus expressing CD59 showed protective effects.
- MAC deposition was quantified and showed a 62.1% reduction with CD59 treatment.
Takeaway
This study shows that a special protein called soluble CD59 can help protect liver blood vessels from damage caused by the immune system.
Methodology
The study used an in vivo model of human complement activation on murine liver vascular endothelium and tested the effects of adenovirus-expressed soluble CD59.
Limitations
The study primarily focuses on murine models, which may not fully replicate human responses.
Participant Demographics
C57BL6/J and Balb/C mice aged 6–10 weeks.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website